Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Interventional × erdafitinib × Clear all

Phase

Status

Active not recruiting 10 Completed 7 Recruiting 4 Terminated 3 Withdrawn 1 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Cisplatin 107 Carboplatin 105 Drug Therapy 92 Oxaliplatin 91 Capecitabine 83 Bevacizumab 79 Paclitaxel 77 pembrolizumab 76 Cyclophosphamide 74 Gemcitabine 73 Radiotherapy 71 tislelizumab 68 Specimen Handling 57 Fluorouracil 55 toripalimab 54 Injections 49 sintilimab 48 Docetaxel 48 Magnetic Resonance Spectroscopy 45 130-nm albumin-bound paclitaxel 44 Surgical Procedures, Operative 42 Leucovorin 39 Pemetrexed 37 Biopsy 37 fludarabine 36 anlotinib 36 Standard of Care 35 Radiosurgery 35 lenvatinib 33 Irinotecan 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06692491 2024-11-18

SPRING

Peking University Shenzhen Hospital

Phase 2 Not yet recruiting

Rare Tumour

Data powered by HemOnc (CC BY 4.0) Colophon ⚡